prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 | 39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |50 |review
RODES TEIXIDOR, J.y GUARDIA MASSO, J. Medicina Interna, Ed. Masson. 1997.IIc2.

CECIL. Tratado de Medicina Interna. 20 Ed. Mc Graw-Hill Interamericana. 1997IIc3.

 FARRERAS y ROZMAN. Medicina Interna. 12 Ed. Ed. Doyma. 1992.IIc4.

 HARRISON. Principios de Med. Interna. 13 Ed. Ed. Interamericana. 1996.

P Jobanputra et al. The clinical effectiveness and cost-effectiveness of new drug treatments for rheumatoid arthritis: etenercept and infliximab. NICE 2002 ( http://www.nice.org.uk/Docref.asp?d=29675)

P Emery et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Annals of Rheumatic Disease 2002 61: 290-297.